Guoyi Corporation (688828.SH) has issued its prospectus for an initial public offering and listing on Shanghai's Sci-Tech Innovation Board (STAR Market). The company plans to issue 40.01 million new shares, representing approximately 10% of its total share capital after the offering.
The initial strategic placement will consist of 8.002 million shares, accounting for 20.00% of the total offering. The final strategic placement ratio and amount will be determined after the issue price is set on T-2 day. Any difference between the final and initial strategic placement allotments will be adjusted according to the principles of the clawback mechanism. The subscription date is set for July 31, 2026.
Since its establishment, the issuer has focused on the research and development of high-end scientific instruments. It serves universities, research institutes, and enterprises globally across fields such as quantum technology, materials science, chemistry and chemical engineering, biomedicine, and advanced manufacturing. The company provides the high-end scientific instrument equipment, core key components like enhanced quantum sensors, and solutions necessary for frontier scientific exploration, actively contributing to reducing import dependency in related sectors.
During the reporting period, the company achieved main business revenues of 389.5064 million yuan, 483.7542 million yuan, and 662.6571 million yuan, respectively, with a compound annual growth rate close to 30% over the past three years. It has established business segments in quantum information technology, spin resonance, electron microscopy, measurement while drilling, and gas adsorption analysis.
For the first quarter of 2026 (January to March), the company's operating revenue was 52.672 million yuan, showing a slight year-on-year decrease. During the same period, total profit, net profit attributable to owners of the parent company, and net profit attributable to owners of the parent company after deducting non-recurring gains and losses all saw an expanded loss scale compared to the same period last year.
This was primarily due to two factors: first, the expansion of the domestic and international sales teams alongside business growth led to an increase in employee compensation; second, the initiation of new instrument R&D projects resulted in an expansion of the R&D team, with corresponding year-on-year increases in R&D personnel compensation and material costs.
Planned Use of Proceeds
The funds raised from this offering are intended primarily for the following projects: the Industrialization Project for High-End Scientific Instruments, the Quantum Technology Development Research Institute Construction Project, and the Application Center Network Construction Project. The planned amount of raised capital to be invested is 1.169 billion yuan.
Comments